Global DTIs for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 137
Published Date: 16 Oct 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Direct Thrombin Inhibitors (DTIs) for injection are a category of anticoagulant medications that directly inhibit thrombin, a key enzyme in the blood clotting process. By blocking thrombin's ability to convert fibrinogen into fibrin, DTIs prevent the formation of blood clots. Administered via intravenous or subcutaneous injection, these drugs are used primarily in hospital settings for conditions requiring acute anticoagulation, such as during surgeries or in patients with deep vein thrombosis or pulmonary embolism.
According to our (Global Info Research) latest study, the global DTIs for Injection market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
The market for Direct Thrombin Inhibitors (DTIs) for injection has evolved significantly in recent years, driven by their advantages in acute anticoagulation settings. Initially, DTIs were introduced to address limitations of traditional anticoagulants like heparin, offering benefits such as direct inhibition of thrombin, which simplifies the management of anticoagulation. The increasing prevalence of conditions such as deep vein thrombosis (DVT) and pulmonary embolism, alongside advancements in surgical techniques, has spurred demand for these specialized medications. Their use in high-risk settings, including complex surgeries and critical care, has solidified their role in acute medical management.
Competition in the DTI market has intensified with the introduction of several new products, each striving to offer improved safety profiles, efficacy, and convenience. For example, bivalirudin and argatroban have emerged as leading options, with distinct advantages in specific clinical scenarios. This competitive landscape has driven innovation and refinement in DTI formulations, including enhancements in delivery methods and dosing regimens. Despite this, the market remains relatively niche compared to broader anticoagulant categories, primarily due to the specific clinical indications and higher costs associated with injectable DTIs.
Looking ahead, the DTI market is poised for steady growth, driven by ongoing advancements in medical technology and increasing adoption in surgical and intensive care settings. Continued research and development efforts are expected to focus on improving the efficacy, safety, and patient outcomes associated with these drugs. However, challenges such as high costs and the emergence of alternative anticoagulants may impact market dynamics. Overall, the market for DTIs for injection remains dynamic, with strong prospects tied to their critical role in managing acute thrombotic events.
This report is a detailed and comprehensive analysis for global DTIs for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global DTIs for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global DTIs for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global DTIs for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global DTIs for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for DTIs for Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global DTIs for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mitsubishi Tanabe Pharma, Pfizer, Sandoz, The Medicines Company, Accord Healthcare, Apotex, Aurobindo Pharma, GlaxoSmithKline, Teva Pharmaceutical, Eugia Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
DTIs for Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Argatroban
Bivalirudin
Other
Market segment by Application
Deep Vein Thrombosis
Pulmonary Embolism
Atrial Fibrillation
Other
Major players covered
Mitsubishi Tanabe Pharma
Pfizer
Sandoz
The Medicines Company
Accord Healthcare
Apotex
Aurobindo Pharma
GlaxoSmithKline
Teva Pharmaceutical
Eugia Pharma
Dr.Reddy's Laboratories
Yangtze River Pharmaceutical
BrightGene
Lunan Pharmaceutical
CSPC Ouyi Pharmaceutical
Beijing SL Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe DTIs for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of DTIs for Injection, with price, sales quantity, revenue, and global market share of DTIs for Injection from 2019 to 2024.
Chapter 3, the DTIs for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the DTIs for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and DTIs for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of DTIs for Injection.
Chapter 14 and 15, to describe DTIs for Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global DTIs for Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Argatroban
1.3.3 Bivalirudin
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global DTIs for Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Deep Vein Thrombosis
1.4.3 Pulmonary Embolism
1.4.4 Atrial Fibrillation
1.4.5 Other
1.5 Global DTIs for Injection Market Size & Forecast
1.5.1 Global DTIs for Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global DTIs for Injection Sales Quantity (2019-2030)
1.5.3 Global DTIs for Injection Average Price (2019-2030)
2.1 Mitsubishi Tanabe Pharma
2.1.1 Mitsubishi Tanabe Pharma Details
2.1.2 Mitsubishi Tanabe Pharma Major Business
2.1.3 Mitsubishi Tanabe Pharma DTIs for Injection Product and Services
2.1.4 Mitsubishi Tanabe Pharma DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer DTIs for Injection Product and Services
2.2.4 Pfizer DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz DTIs for Injection Product and Services
2.3.4 Sandoz DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Sandoz Recent Developments/Updates
2.4 The Medicines Company
2.4.1 The Medicines Company Details
2.4.2 The Medicines Company Major Business
2.4.3 The Medicines Company DTIs for Injection Product and Services
2.4.4 The Medicines Company DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 The Medicines Company Recent Developments/Updates
2.5 Accord Healthcare
2.5.1 Accord Healthcare Details
2.5.2 Accord Healthcare Major Business
2.5.3 Accord Healthcare DTIs for Injection Product and Services
2.5.4 Accord Healthcare DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Accord Healthcare Recent Developments/Updates
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex DTIs for Injection Product and Services
2.6.4 Apotex DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Apotex Recent Developments/Updates
2.7 Aurobindo Pharma
2.7.1 Aurobindo Pharma Details
2.7.2 Aurobindo Pharma Major Business
2.7.3 Aurobindo Pharma DTIs for Injection Product and Services
2.7.4 Aurobindo Pharma DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Aurobindo Pharma Recent Developments/Updates
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline DTIs for Injection Product and Services
2.8.4 GlaxoSmithKline DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GlaxoSmithKline Recent Developments/Updates
2.9 Teva Pharmaceutical
2.9.1 Teva Pharmaceutical Details
2.9.2 Teva Pharmaceutical Major Business
2.9.3 Teva Pharmaceutical DTIs for Injection Product and Services
2.9.4 Teva Pharmaceutical DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Pharmaceutical Recent Developments/Updates
2.10 Eugia Pharma
2.10.1 Eugia Pharma Details
2.10.2 Eugia Pharma Major Business
2.10.3 Eugia Pharma DTIs for Injection Product and Services
2.10.4 Eugia Pharma DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eugia Pharma Recent Developments/Updates
2.11 Dr.Reddy's Laboratories
2.11.1 Dr.Reddy's Laboratories Details
2.11.2 Dr.Reddy's Laboratories Major Business
2.11.3 Dr.Reddy's Laboratories DTIs for Injection Product and Services
2.11.4 Dr.Reddy's Laboratories DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dr.Reddy's Laboratories Recent Developments/Updates
2.12 Yangtze River Pharmaceutical
2.12.1 Yangtze River Pharmaceutical Details
2.12.2 Yangtze River Pharmaceutical Major Business
2.12.3 Yangtze River Pharmaceutical DTIs for Injection Product and Services
2.12.4 Yangtze River Pharmaceutical DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Yangtze River Pharmaceutical Recent Developments/Updates
2.13 BrightGene
2.13.1 BrightGene Details
2.13.2 BrightGene Major Business
2.13.3 BrightGene DTIs for Injection Product and Services
2.13.4 BrightGene DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 BrightGene Recent Developments/Updates
2.14 Lunan Pharmaceutical
2.14.1 Lunan Pharmaceutical Details
2.14.2 Lunan Pharmaceutical Major Business
2.14.3 Lunan Pharmaceutical DTIs for Injection Product and Services
2.14.4 Lunan Pharmaceutical DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Lunan Pharmaceutical Recent Developments/Updates
2.15 CSPC Ouyi Pharmaceutical
2.15.1 CSPC Ouyi Pharmaceutical Details
2.15.2 CSPC Ouyi Pharmaceutical Major Business
2.15.3 CSPC Ouyi Pharmaceutical DTIs for Injection Product and Services
2.15.4 CSPC Ouyi Pharmaceutical DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
2.16 Beijing SL Pharmaceutical
2.16.1 Beijing SL Pharmaceutical Details
2.16.2 Beijing SL Pharmaceutical Major Business
2.16.3 Beijing SL Pharmaceutical DTIs for Injection Product and Services
2.16.4 Beijing SL Pharmaceutical DTIs for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Beijing SL Pharmaceutical Recent Developments/Updates
3.1 Global DTIs for Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global DTIs for Injection Revenue by Manufacturer (2019-2024)
3.3 Global DTIs for Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of DTIs for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 DTIs for Injection Manufacturer Market Share in 2023
3.4.3 Top 6 DTIs for Injection Manufacturer Market Share in 2023
3.5 DTIs for Injection Market: Overall Company Footprint Analysis
3.5.1 DTIs for Injection Market: Region Footprint
3.5.2 DTIs for Injection Market: Company Product Type Footprint
3.5.3 DTIs for Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global DTIs for Injection Market Size by Region
4.1.1 Global DTIs for Injection Sales Quantity by Region (2019-2030)
4.1.2 Global DTIs for Injection Consumption Value by Region (2019-2030)
4.1.3 Global DTIs for Injection Average Price by Region (2019-2030)
4.2 North America DTIs for Injection Consumption Value (2019-2030)
4.3 Europe DTIs for Injection Consumption Value (2019-2030)
4.4 Asia-Pacific DTIs for Injection Consumption Value (2019-2030)
4.5 South America DTIs for Injection Consumption Value (2019-2030)
4.6 Middle East & Africa DTIs for Injection Consumption Value (2019-2030)
5.1 Global DTIs for Injection Sales Quantity by Type (2019-2030)
5.2 Global DTIs for Injection Consumption Value by Type (2019-2030)
5.3 Global DTIs for Injection Average Price by Type (2019-2030)
6.1 Global DTIs for Injection Sales Quantity by Application (2019-2030)
6.2 Global DTIs for Injection Consumption Value by Application (2019-2030)
6.3 Global DTIs for Injection Average Price by Application (2019-2030)
7.1 North America DTIs for Injection Sales Quantity by Type (2019-2030)
7.2 North America DTIs for Injection Sales Quantity by Application (2019-2030)
7.3 North America DTIs for Injection Market Size by Country
7.3.1 North America DTIs for Injection Sales Quantity by Country (2019-2030)
7.3.2 North America DTIs for Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe DTIs for Injection Sales Quantity by Type (2019-2030)
8.2 Europe DTIs for Injection Sales Quantity by Application (2019-2030)
8.3 Europe DTIs for Injection Market Size by Country
8.3.1 Europe DTIs for Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe DTIs for Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific DTIs for Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific DTIs for Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific DTIs for Injection Market Size by Region
9.3.1 Asia-Pacific DTIs for Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific DTIs for Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America DTIs for Injection Sales Quantity by Type (2019-2030)
10.2 South America DTIs for Injection Sales Quantity by Application (2019-2030)
10.3 South America DTIs for Injection Market Size by Country
10.3.1 South America DTIs for Injection Sales Quantity by Country (2019-2030)
10.3.2 South America DTIs for Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa DTIs for Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa DTIs for Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa DTIs for Injection Market Size by Country
11.3.1 Middle East & Africa DTIs for Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa DTIs for Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 DTIs for Injection Market Drivers
12.2 DTIs for Injection Market Restraints
12.3 DTIs for Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of DTIs for Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of DTIs for Injection
13.3 DTIs for Injection Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 DTIs for Injection Typical Distributors
14.3 DTIs for Injection Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global DTIs for Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global DTIs for Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Mitsubishi Tanabe Pharma Major Business
Table 5. Mitsubishi Tanabe Pharma DTIs for Injection Product and Services
Table 6. Mitsubishi Tanabe Pharma DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer DTIs for Injection Product and Services
Table 11. Pfizer DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Sandoz Basic Information, Manufacturing Base and Competitors
Table 14. Sandoz Major Business
Table 15. Sandoz DTIs for Injection Product and Services
Table 16. Sandoz DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Sandoz Recent Developments/Updates
Table 18. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 19. The Medicines Company Major Business
Table 20. The Medicines Company DTIs for Injection Product and Services
Table 21. The Medicines Company DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. The Medicines Company Recent Developments/Updates
Table 23. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 24. Accord Healthcare Major Business
Table 25. Accord Healthcare DTIs for Injection Product and Services
Table 26. Accord Healthcare DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Accord Healthcare Recent Developments/Updates
Table 28. Apotex Basic Information, Manufacturing Base and Competitors
Table 29. Apotex Major Business
Table 30. Apotex DTIs for Injection Product and Services
Table 31. Apotex DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Apotex Recent Developments/Updates
Table 33. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Aurobindo Pharma Major Business
Table 35. Aurobindo Pharma DTIs for Injection Product and Services
Table 36. Aurobindo Pharma DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Aurobindo Pharma Recent Developments/Updates
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Major Business
Table 40. GlaxoSmithKline DTIs for Injection Product and Services
Table 41. GlaxoSmithKline DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GlaxoSmithKline Recent Developments/Updates
Table 43. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Teva Pharmaceutical Major Business
Table 45. Teva Pharmaceutical DTIs for Injection Product and Services
Table 46. Teva Pharmaceutical DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Teva Pharmaceutical Recent Developments/Updates
Table 48. Eugia Pharma Basic Information, Manufacturing Base and Competitors
Table 49. Eugia Pharma Major Business
Table 50. Eugia Pharma DTIs for Injection Product and Services
Table 51. Eugia Pharma DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Eugia Pharma Recent Developments/Updates
Table 53. Dr.Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 54. Dr.Reddy's Laboratories Major Business
Table 55. Dr.Reddy's Laboratories DTIs for Injection Product and Services
Table 56. Dr.Reddy's Laboratories DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Dr.Reddy's Laboratories Recent Developments/Updates
Table 58. Yangtze River Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Yangtze River Pharmaceutical Major Business
Table 60. Yangtze River Pharmaceutical DTIs for Injection Product and Services
Table 61. Yangtze River Pharmaceutical DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Yangtze River Pharmaceutical Recent Developments/Updates
Table 63. BrightGene Basic Information, Manufacturing Base and Competitors
Table 64. BrightGene Major Business
Table 65. BrightGene DTIs for Injection Product and Services
Table 66. BrightGene DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. BrightGene Recent Developments/Updates
Table 68. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Lunan Pharmaceutical Major Business
Table 70. Lunan Pharmaceutical DTIs for Injection Product and Services
Table 71. Lunan Pharmaceutical DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Lunan Pharmaceutical Recent Developments/Updates
Table 73. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. CSPC Ouyi Pharmaceutical Major Business
Table 75. CSPC Ouyi Pharmaceutical DTIs for Injection Product and Services
Table 76. CSPC Ouyi Pharmaceutical DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 78. Beijing SL Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Beijing SL Pharmaceutical Major Business
Table 80. Beijing SL Pharmaceutical DTIs for Injection Product and Services
Table 81. Beijing SL Pharmaceutical DTIs for Injection Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Beijing SL Pharmaceutical Recent Developments/Updates
Table 83. Global DTIs for Injection Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 84. Global DTIs for Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 85. Global DTIs for Injection Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 86. Market Position of Manufacturers in DTIs for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 87. Head Office and DTIs for Injection Production Site of Key Manufacturer
Table 88. DTIs for Injection Market: Company Product Type Footprint
Table 89. DTIs for Injection Market: Company Product Application Footprint
Table 90. DTIs for Injection New Market Entrants and Barriers to Market Entry
Table 91. DTIs for Injection Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global DTIs for Injection Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 93. Global DTIs for Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 94. Global DTIs for Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 95. Global DTIs for Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 96. Global DTIs for Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 97. Global DTIs for Injection Average Price by Region (2019-2024) & (US$/Unit)
Table 98. Global DTIs for Injection Average Price by Region (2025-2030) & (US$/Unit)
Table 99. Global DTIs for Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 100. Global DTIs for Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 101. Global DTIs for Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 102. Global DTIs for Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 103. Global DTIs for Injection Average Price by Type (2019-2024) & (US$/Unit)
Table 104. Global DTIs for Injection Average Price by Type (2025-2030) & (US$/Unit)
Table 105. Global DTIs for Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 106. Global DTIs for Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 107. Global DTIs for Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Global DTIs for Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Global DTIs for Injection Average Price by Application (2019-2024) & (US$/Unit)
Table 110. Global DTIs for Injection Average Price by Application (2025-2030) & (US$/Unit)
Table 111. North America DTIs for Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 112. North America DTIs for Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 113. North America DTIs for Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 114. North America DTIs for Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 115. North America DTIs for Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 116. North America DTIs for Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 117. North America DTIs for Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 118. North America DTIs for Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 119. Europe DTIs for Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 120. Europe DTIs for Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 121. Europe DTIs for Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 122. Europe DTIs for Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 123. Europe DTIs for Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 124. Europe DTIs for Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 125. Europe DTIs for Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 126. Europe DTIs for Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Asia-Pacific DTIs for Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 128. Asia-Pacific DTIs for Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 129. Asia-Pacific DTIs for Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 130. Asia-Pacific DTIs for Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 131. Asia-Pacific DTIs for Injection Sales Quantity by Region (2019-2024) & (K Units)
Table 132. Asia-Pacific DTIs for Injection Sales Quantity by Region (2025-2030) & (K Units)
Table 133. Asia-Pacific DTIs for Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Asia-Pacific DTIs for Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 135. South America DTIs for Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 136. South America DTIs for Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 137. South America DTIs for Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 138. South America DTIs for Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 139. South America DTIs for Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 140. South America DTIs for Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 141. South America DTIs for Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 142. South America DTIs for Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 143. Middle East & Africa DTIs for Injection Sales Quantity by Type (2019-2024) & (K Units)
Table 144. Middle East & Africa DTIs for Injection Sales Quantity by Type (2025-2030) & (K Units)
Table 145. Middle East & Africa DTIs for Injection Sales Quantity by Application (2019-2024) & (K Units)
Table 146. Middle East & Africa DTIs for Injection Sales Quantity by Application (2025-2030) & (K Units)
Table 147. Middle East & Africa DTIs for Injection Sales Quantity by Country (2019-2024) & (K Units)
Table 148. Middle East & Africa DTIs for Injection Sales Quantity by Country (2025-2030) & (K Units)
Table 149. Middle East & Africa DTIs for Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 150. Middle East & Africa DTIs for Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 151. DTIs for Injection Raw Material
Table 152. Key Manufacturers of DTIs for Injection Raw Materials
Table 153. DTIs for Injection Typical Distributors
Table 154. DTIs for Injection Typical Customers
List of Figures
Figure 1. DTIs for Injection Picture
Figure 2. Global DTIs for Injection Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global DTIs for Injection Revenue Market Share by Type in 2023
Figure 4. Argatroban Examples
Figure 5. Bivalirudin Examples
Figure 6. Other Examples
Figure 7. Global DTIs for Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global DTIs for Injection Revenue Market Share by Application in 2023
Figure 9. Deep Vein Thrombosis Examples
Figure 10. Pulmonary Embolism Examples
Figure 11. Atrial Fibrillation Examples
Figure 12. Other Examples
Figure 13. Global DTIs for Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 14. Global DTIs for Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 15. Global DTIs for Injection Sales Quantity (2019-2030) & (K Units)
Figure 16. Global DTIs for Injection Price (2019-2030) & (US$/Unit)
Figure 17. Global DTIs for Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 18. Global DTIs for Injection Revenue Market Share by Manufacturer in 2023
Figure 19. Producer Shipments of DTIs for Injection by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 20. Top 3 DTIs for Injection Manufacturer (Revenue) Market Share in 2023
Figure 21. Top 6 DTIs for Injection Manufacturer (Revenue) Market Share in 2023
Figure 22. Global DTIs for Injection Sales Quantity Market Share by Region (2019-2030)
Figure 23. Global DTIs for Injection Consumption Value Market Share by Region (2019-2030)
Figure 24. North America DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 25. Europe DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 26. Asia-Pacific DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 27. South America DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 28. Middle East & Africa DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 29. Global DTIs for Injection Sales Quantity Market Share by Type (2019-2030)
Figure 30. Global DTIs for Injection Consumption Value Market Share by Type (2019-2030)
Figure 31. Global DTIs for Injection Average Price by Type (2019-2030) & (US$/Unit)
Figure 32. Global DTIs for Injection Sales Quantity Market Share by Application (2019-2030)
Figure 33. Global DTIs for Injection Revenue Market Share by Application (2019-2030)
Figure 34. Global DTIs for Injection Average Price by Application (2019-2030) & (US$/Unit)
Figure 35. North America DTIs for Injection Sales Quantity Market Share by Type (2019-2030)
Figure 36. North America DTIs for Injection Sales Quantity Market Share by Application (2019-2030)
Figure 37. North America DTIs for Injection Sales Quantity Market Share by Country (2019-2030)
Figure 38. North America DTIs for Injection Consumption Value Market Share by Country (2019-2030)
Figure 39. United States DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 40. Canada DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 41. Mexico DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 42. Europe DTIs for Injection Sales Quantity Market Share by Type (2019-2030)
Figure 43. Europe DTIs for Injection Sales Quantity Market Share by Application (2019-2030)
Figure 44. Europe DTIs for Injection Sales Quantity Market Share by Country (2019-2030)
Figure 45. Europe DTIs for Injection Consumption Value Market Share by Country (2019-2030)
Figure 46. Germany DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 47. France DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 48. United Kingdom DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 49. Russia DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 50. Italy DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 51. Asia-Pacific DTIs for Injection Sales Quantity Market Share by Type (2019-2030)
Figure 52. Asia-Pacific DTIs for Injection Sales Quantity Market Share by Application (2019-2030)
Figure 53. Asia-Pacific DTIs for Injection Sales Quantity Market Share by Region (2019-2030)
Figure 54. Asia-Pacific DTIs for Injection Consumption Value Market Share by Region (2019-2030)
Figure 55. China DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 56. Japan DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 57. South Korea DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 58. India DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 59. Southeast Asia DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 60. Australia DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 61. South America DTIs for Injection Sales Quantity Market Share by Type (2019-2030)
Figure 62. South America DTIs for Injection Sales Quantity Market Share by Application (2019-2030)
Figure 63. South America DTIs for Injection Sales Quantity Market Share by Country (2019-2030)
Figure 64. South America DTIs for Injection Consumption Value Market Share by Country (2019-2030)
Figure 65. Brazil DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 66. Argentina DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 67. Middle East & Africa DTIs for Injection Sales Quantity Market Share by Type (2019-2030)
Figure 68. Middle East & Africa DTIs for Injection Sales Quantity Market Share by Application (2019-2030)
Figure 69. Middle East & Africa DTIs for Injection Sales Quantity Market Share by Country (2019-2030)
Figure 70. Middle East & Africa DTIs for Injection Consumption Value Market Share by Country (2019-2030)
Figure 71. Turkey DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 72. Egypt DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 73. Saudi Arabia DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 74. South Africa DTIs for Injection Consumption Value (2019-2030) & (USD Million)
Figure 75. DTIs for Injection Market Drivers
Figure 76. DTIs for Injection Market Restraints
Figure 77. DTIs for Injection Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of DTIs for Injection in 2023
Figure 80. Manufacturing Process Analysis of DTIs for Injection
Figure 81. DTIs for Injection Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Mitsubishi Tanabe Pharma Pfizer Sandoz The Medicines Company Accord Healthcare Apotex Aurobindo Pharma GlaxoSmithKline Teva Pharmaceutical Eugia Pharma Dr.Reddy's Laboratories Yangtze River Pharmaceutical BrightGene Lunan Pharmaceutical CSPC Ouyi Pharmaceutical Beijing SL Pharmaceutical
16 Oct 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
